HBB Earnings

HBB reported its earnings on 2025-11-05, showcasing a revenue of 132.78M against an estimate of , resulting in a 0% surprise. The EPS was 0.12, surpassing the expected 0 by 0%. The stock experienced a -4.52% price change on the earnings day and a -3.9% change over the next five days, reflecting market reactions to the results.

Following HBB's earnings announcement on 2025-11-05, the stock price moved by -4.52% on the day of the release. Over the subsequent five days, it saw a -3.9% change. Historically, HBB's stock price tends to shift by an average of 0.2% in the 10 days leading up to earnings and 1.05% in the 10 days following, providing insight into potential market.

For , analysts estimate HBB's annual revenue to reach undefined, while the EPS is projected at . These estimates reflect recent revisions, with revenue estimates revised upward by 0.24% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between HBB's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for were revised upward by 0.24%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, HBB's stock price typically moves by 0.2% in the 10 days before its earnings and 1.05% in the 10 days after. For the upcoming earnings, analysts expect an EPS of and revenue of undefined.

The earnings call shows mixed results: strong commercial and health division growth, positive operating profit, and increased gross margins are countered by declines in U.S. consumer business and full-year revenue. The Q&A highlights uncertainty in tariff impacts and lack of clarity on sales resumption details. While new partnerships and product pipelines offer future growth potential, increased costs and economic uncertainties pose risks. The combination of these factors suggests a neutral stock price movement over the next two weeks.